BIOPROJET Societe de recherche

BIOPROJET is a European pharmaceutical company created from basic research.

BIOPROJET is a French independent (privately-owned) research company created in 1982 by Dr Jeanne-Marie Lecomte and Prof. Jean-Charles Schwartz.

The activity of BIOPROJET is centered upon Design and Development of novel classes of drugs, an aim reached by close interaction:

  • with Academic Laboratories on one side,
  • subcontracting industrial companies on the other,
  • and, more recently, by BIOPROJET BIOTECH.

This strategy has resulted so far in the development of:

  • one drug up to marketing in France and worldwide (Tiorfan®/Hidrasec®, racecadotrilINN, an intestinal antisecretory drug),
  • three drugs up to Phase III clinical trials in following fields : gastro enterology, cardiovascular and CNS (dexecadotrilINN, BP 1.137 and BF 2.649)
  • two drugs up to Phase I clinical trials in CNS (BP 1.3656 and BP 1. 4979),
  • several other compounds in preclinical development.

Each of these compounds represents the first one in a novel therapeutic class.

BIOPROJET SCR is in charge of the French and international patent protection
(52 prioritary patent applications) and is the exclusive owner of the patent rights and of the know-how.

BIOPROJET SCR is the owner of BIOPROJET PHARMA, a pharmaceutical company.

Hidrasec
Headquarters BIOPROJET

30, rue des Francs-Bourgeois
75003 Paris
France

Founders members
jeanne-marie lecomte

Dr Jeanne-Marie Lecomte

jean-charles schwartz

Prof Jean-Charles Schwartz